tradingkey.logo
tradingkey.logo
Search

Abbott Laboratories

ABT
Add to Watchlist
103.040USD
+2.290+2.27%
Market hours ETQuotes delayed by 15 min
178.94BMarket Cap
28.59P/E TTM

ABT Financials

See Abbott Laboratories's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Abbott Laboratories Earnings Date

Latest Release
Jul 16, 2026
EPS / Forecast
0.53/1.28
Revenue / Forecast
12.59B/12.50B
Period
FY2025 Earnings
Revenue(YoY)
44.33B
5.67%
EPS(YoY)
3.75
-51.35%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-47.82%0.53
-18.87%0.62
-80.78%1.02
-0.27%0.94
36.61%1.02
8.23%0.76
479.60%5.31
14.57%0.95
-5.46%0.75
-6.97%0.70
54.67%0.92
--0.83
--0.79
--0.76
--0.59
--3.36
----
----
----
----
----
Revenue
13.02%12.59B
7.78%11.16B
4.42%11.46B
6.90%11.37B
7.37%11.14B
3.95%10.36B
7.16%10.97B
4.85%10.63B
4.00%10.38B
2.23%9.96B
1.49%10.24B
-2.56%10.14B
-11.36%9.98B
-18.06%9.75B
-12.01%10.09B
-4.74%10.41B
10.11%11.26B
13.76%11.89B
7.17%11.47B
23.44%10.93B
----
Net Profit
-47.84%928.00M
-18.72%1.08B
-80.76%1.78B
-0.12%1.64B
36.64%1.78B
8.16%1.32B
478.98%9.23B
14.62%1.65B
-5.31%1.30B
-7.06%1.23B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-48.06%1.03B
-31.67%1.44B
69.72%2.02B
36.48%2.45B
-8.00%1.99B
70.45%2.10B
----
Net Margin
-53.85%7.37%
-24.59%9.65%
-81.57%15.50%
-6.57%14.46%
27.25%15.97%
4.05%12.79%
440.31%84.10%
9.32%15.48%
-8.95%12.55%
-9.08%12.29%
52.05%15.56%
--14.16%
--13.78%
--13.52%
--10.24%
--17.58%
----
----
----
----
----
Gross Margin
-0.69%52.80%
-0.98%52.42%
4.92%53.44%
0.23%51.94%
3.51%53.17%
4.65%52.93%
-0.24%50.94%
3.96%51.82%
2.34%51.36%
-0.02%50.58%
3.01%51.06%
--49.85%
--50.19%
--50.59%
--49.57%
--52.13%
----
----
----
----
----
Debt to assets ratio
----
89.64%30.83%
-14.06%14.91%
-23.69%15.37%
-20.83%16.00%
-19.22%16.26%
-13.47%17.35%
-6.48%20.14%
-12.01%20.21%
-12.11%20.13%
-11.02%20.05%
--21.54%
--22.97%
--22.90%
--22.53%
--22.55%
----
----
----
----
----
Revenue
13.02%12.59B
7.78%11.16B
4.42%11.46B
6.90%11.37B
7.37%11.14B
3.95%10.36B
7.16%10.97B
4.85%10.63B
4.00%10.38B
2.23%9.96B
1.49%10.24B
-2.56%10.14B
-11.36%9.98B
-18.06%9.75B
-12.01%10.09B
-4.74%10.41B
10.11%11.26B
13.76%11.89B
7.17%11.47B
23.44%10.93B
----
Operating profit
0.52%2.13B
-22.66%1.34B
15.51%2.33B
14.02%2.16B
22.38%2.12B
20.68%1.74B
4.99%2.02B
11.59%1.90B
10.17%1.73B
-5.57%1.44B
47.39%1.92B
-9.62%1.70B
-33.75%1.57B
-47.60%1.53B
-48.58%1.30B
-26.15%1.88B
70.32%2.38B
38.01%2.91B
-1.05%2.54B
81.41%2.55B
----
Net Profit
-47.84%928.00M
-18.72%1.08B
-80.76%1.78B
-0.12%1.64B
36.64%1.78B
8.16%1.32B
478.98%9.23B
14.62%1.65B
-5.31%1.30B
-7.06%1.23B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
-48.06%1.03B
-31.67%1.44B
69.72%2.02B
36.48%2.45B
-8.00%1.99B
70.45%2.10B
----
Current assets
----
10.17%25.51B
9.89%26.00B
4.36%24.84B
5.84%24.47B
3.47%23.15B
4.35%23.66B
5.02%23.80B
-1.64%23.12B
-8.21%22.38B
-10.13%22.67B
-8.78%22.66B
-5.81%23.50B
4.05%24.38B
4.06%25.22B
5.76%24.84B
10.29%24.96B
7.39%23.43B
18.58%24.24B
35.09%23.49B
31.39%22.63B
Total current liabilities
----
41.32%18.38B
16.52%16.50B
-2.15%14.58B
-2.33%13.44B
-7.25%13.00B
2.28%14.16B
14.26%14.90B
-4.11%13.76B
-3.50%14.02B
-10.64%13.84B
-2.42%13.04B
15.80%14.35B
14.89%14.53B
18.19%15.49B
3.87%13.37B
-1.76%12.39B
1.48%12.65B
10.06%13.11B
25.45%12.87B
15.10%12.61B
Total assets
----
35.58%110.43B
6.51%86.71B
13.21%84.18B
15.04%84.00B
12.39%81.45B
11.20%81.41B
3.14%74.36B
-0.46%73.02B
-1.80%72.47B
-1.64%73.21B
-0.98%72.09B
-1.14%73.35B
-0.29%73.79B
-1.01%74.44B
-1.35%72.80B
1.27%74.20B
1.68%74.01B
3.65%75.20B
6.88%73.80B
6.53%73.27B
Total liabilities
----
78.26%57.73B
1.28%33.94B
-4.11%32.92B
-0.86%33.17B
-3.11%32.38B
-2.54%33.51B
-0.20%34.33B
-6.93%33.46B
-8.58%33.42B
-8.38%34.39B
-6.83%34.40B
-4.10%35.95B
-4.73%36.56B
-4.18%37.53B
-5.72%36.92B
-4.47%37.49B
-1.59%38.38B
-0.94%39.17B
4.56%39.16B
3.32%39.24B
Total equity
----
7.41%52.70B
10.17%52.77B
28.07%51.26B
28.49%50.83B
25.67%49.06B
23.37%47.90B
6.19%40.03B
5.76%39.56B
4.86%39.04B
5.21%38.83B
5.04%37.69B
1.87%37.40B
4.50%37.23B
2.45%36.91B
3.60%35.88B
7.90%36.72B
5.45%35.63B
9.15%36.02B
9.63%34.64B
10.49%34.03B
Net operating income
----
-7.20%1.31B
15.59%3.31B
3.03%2.79B
4.44%2.05B
38.24%1.42B
-5.60%2.87B
44.11%2.71B
62.93%1.96B
-10.32%1.02B
30.61%3.04B
-32.48%1.88B
-50.08%1.20B
-44.65%1.14B
-24.16%2.33B
2.92%2.78B
13.25%2.41B
-21.69%2.06B
-19.25%3.07B
30.74%2.70B
60.97%2.13B
Net investment
----
-4224.26%-20.32B
-5.43%-913.00M
23.06%-457.00M
-28.48%-582.00M
-10.59%-470.00M
-5.10%-866.00M
6.31%-594.00M
62.65%-453.00M
8.01%-425.00M
-30.38%-824.00M
-30.99%-634.00M
-359.47%-1.21B
-28.33%-462.00M
5.81%-632.00M
25.65%-484.00M
0.00%-264.00M
14.69%-360.00M
8.21%-671.00M
-37.92%-651.00M
57.35%-264.00M
Net financing
----
942.48%17.31B
24.93%-1.40B
-11.68%-1.76B
-38.69%-1.10B
-74.74%-2.06B
9.31%-1.86B
32.65%-1.58B
38.63%-791.00M
16.60%-1.18B
-40.84%-2.05B
-51.65%-2.34B
-58.55%-1.29B
63.12%-1.41B
22.75%-1.46B
-12.06%-1.54B
35.68%-813.00M
-295.35%-3.82B
-139.64%-1.89B
28.09%-1.38B
-292.10%-1.26B

FAQs

What is the total revenue of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its total revenue reached 44.33B, with a year-on-year change of 41.95B.

What are the current assets of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its current assets were 26.00B, with a year-on-year change of 9.89.

What are the total assets of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its total assets of Abbott Laboratories were 86.71B, with a year-on-year change of 6.51.

What are the total liabilities of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its total liabilities of Abbott Laboratories were 33.94B, with a year-on-year change of 1.28.

What is the total equity of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its total equity of Abbott Laboratories was 52.77B, with a year-on-year change of 10.17.

What is the net operating income of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its net operating income of Abbott Laboratories was 8.36B, with a year-on-year change of 18.70.

What is the net investment of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its net investment of Abbott Laboratories was -2.42B, with a year-on-year change of -3.64.

What is the net financing of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its net financing of Abbott Laboratories was -6.31B, with a year-on-year change of -16.75.

What is the Earnings Per Share (EPS) of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its Earnings Per Share (EPS) was 3.75, with a year-on-year change of -51.35.

What is the net income of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its net income was 6.52B, with a year-on-year change of -51.32.

What is the net margin of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its net profit margin was 14.72, with a year-on-year change of -53.93.

What is the gross margin of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its gross margin was 52.87, with a year-on-year change of 3.50.

What is the debt-to-asset ratio of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its debt-to-asset ratio was 14.91, with a year-on-year change of -14.06.

What is the Return on Equity (ROE) of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its Return on Equity (ROE) was 13.07, with a year-on-year change of -57.92.

What is the Return on Assets (ROA) of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its Return on Assets (ROA) was 7.76, with a year-on-year change of -55.23.

What is the operating profit of Abbott Laboratories?

According to Abbott Laboratories's FY2025 earnings report, its operating profit was 8.36B, with a year-on-year change of 18.70.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.